Cuadro Nacional de medicamentos básicos, una revisión y actualización del grupo G03CA03- G04CB02

Abstract

Abstract: In the present study, the CNMB's Group "G" database was updated by incorporating a comprehensive bibliographic research methodology, using data from updated online platforms, and applying rigorous selection and filtering criteria to ensure the accuracy of the information collected. To facilitate the identification of the included data, the information was initially recorded in the corresponding data sheet and subsequently in the CONASA modification control sheet. During the process, adjustments were made to seven Group "G" therapeutic data sheets, including new guidelines, doses, side effects, precautions, contraindications, and interactions. A comprehensive analysis of clinical cases related to adverse effects and interactions caused by Group "G" medications was also conducted, given their widespread prevalence and clinical use. In conclusion, it is essential to ensure the rational and safe use of medications, complying with international standards and adopting best practices in clinical pharmacology to minimize risks and maximize benefits for patients.